irinotecan has been researched along with Autoimmune Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frese, S; Frese-Schaper, M; Gugger, M; Monestier, M; Zbaeren, J | 1 |
1 other study(ies) available for irinotecan and Autoimmune Diseases
| Article | Year |
|---|---|
Reversal of established lupus nephritis and prolonged survival of New Zealand black x New Zealand white mice treated with the topoisomerase I inhibitor irinotecan.
Topics: Animals; Autoimmune Diseases; Camptothecin; Crosses, Genetic; DNA Topoisomerases, Type I; Enzyme Inhibitors; Female; Irinotecan; Lupus Nephritis; Mice; Mice, Inbred NZB; Proteinuria; Random Allocation; Survival Analysis; Time Factors; Topoisomerase I Inhibitors | 2010 |